Smoothelin is a specific and robust marker for distinction of muscularis propria and muscularis mucosae in the gastrointestinal tract

Histopathology

Volumn 57, Issue 2, 2010, Pages 244-249

  Montani, Matteo ^a   Thiesler, Thore ^a   Kristiansen, Glen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

gastrointestinal tract; immunohistochemistry; smooth muscle actin; smoothelin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; SMOOTHELIN;

ARTICLE; COLON; COLON BIOPSY; COLON TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGUS; ESOPHAGUS BIOPSY; ESOPHAGUS TUMOR; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LAMINA PROPRIA; LARGE INTESTINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH; STOMACH BIOPSY; STOMACH MUSCLE; STOMACH TUMOR;

ACTINS; BIOLOGICAL MARKERS; COLON; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTROINTESTINAL TRACT; HUMANS; IMMUNOHISTOCHEMISTRY; MUCOUS MEMBRANE; MUSCLE PROTEINS; STOMACH; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77955795750     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03618.x     Document Type: Article

References (15)

1. Larghi A, Lightdale CJ, Ross AS et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 2007 39 1086 1091.
2. DeMeester SR. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy. Ann. Thorac. Surg. 2008 85 S747 S750.
3. Chennat J, Konda VJ, Ross AS et al. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma - an American single-center experience. Am. J. Gastroenterol. 2009 104 2684 2692.
4. Repici A, Pellicano R, Strangio G, Danese S, Fagoonee S, Malesci A. Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. Dis. Colon Rectum 2009 52 1502 1515.
5. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest. Endosc. 2003 58 S3 S43.
6. Mandal RV, Forcione DG, Brugge WR, Nishioka NS, Mino-Kenudson M, Lauwers GY. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia. Am. J. Surg. Pathol. 2009 33 620 625.
7. Scudiere JR, Montgomery EA. New treatments, new challenges: pathology's perspective on esophageal carcinoma. Gastroenterol. Clin. North Am. 2009 38 121 133.
8. Odze RD. Update on the diagnosis and treatment of Barrett esophagus and related neoplastic precursor lesions. Arch. Pathol. Lab. Med. 2008 132 1577 1585.
9. Paner GP, Shen SS, Lapetino S et al. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am. J. Surg. Pathol. 2009 33 91 98.
10. Council L, Hameed O. Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma. Mod. Pathol. 2009 22 639 650.
11. van der Loop FT, Schaart G, Timmer ED, Ramaekers FC, van Eys GJ. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J. Cell Biol. 1996 134 401 411.
12. Rensen SS, Thijssen VL, De Vries CJ, Doevendans PA, Detera-Wadleigh SD, Van Eys GJ. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc. Res. 2002 55 850 863.
13. van Eys GJ, Niessen PM, Rensen SS. Smoothelin in vascular smooth muscle cells. Trends Cardiovasc. Med. 2007 17 26 30.
14. Wedel T, Van Eys GJ, Waltregny D, Glenisson W, Castronovo V, Vanderwinden JM. Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders. Neurogastroenterol. Motil. 2006 18 526 538.
15. Niessen P, Rensen S, van Deursen J et al. Smoothelin-a is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology 2005 129 1592 1601.